Unusual Toxoplasma infection of the eye and central nervous system in an HIV-positive patient

Česká verze

Authors: F. Ondriska ^1,2; Ľ. Soják ³; V. Boldiš ²; Ľ. Piesecká ⁴; P. Mikula ⁵; Ľ. Kováč ²
Authors place of work: Trnavská univerzita Trnava, Fakulta zdravotníctva a sociálnej práce, Trnava ¹; Medirex, a. s., člen Medirex Group, Oddelenie parazitológie, Bratislava ²; Klinika infektológie a geografickej medicíny Lekárskej fakulty Univerzity Komenského, Slovenskej zdravotníckej univerzity a Univerzitnej nemocnice Bratislava ³; Infekčná klinika Fakultnej nemocnice, Nitra ⁴; Rádiologická klinika Lekárskej fakulty Univerzity Komenského, Slovenskej zdravotníckej univerzity a Univerzitnej nemocnice Bratislava ⁵
Published in the journal: Epidemiol. Mikrobiol. Imunol. 71, 2022, č. 3, s. 165-170
Category: Původní práce

Summary

Objective: To report on a unique combination of cerebral toxoplasmosis and ocular toxoplasmosis in an HIV-positive patient in Slovakia.

Methods: A 35-year-old heterosexual patient who presented with headache and major seizures underwent computed tomography (CT) and magnetic resonance imaging (MRI). Based on clinical findings, serological tests for toxoplasmosis were performed on serum and ocular fluid specimens. PCR was also used to detect Toxoplasma gondii and cytomegalovirus DNA. Goldmann and Witmer coefficient calculation was applied to demonstrate the synthesis of intraocular IgG antibodies.

Results: CT and MRI revealed cystic lesions suspected of metastasis in the occipital and temporal regions, and we searched for the primary tumor. After vision loss in the left eye, which rapidly progressed to complete blindness, an eye examination detected macular edema. Anti-edema treatment was initiated. HIV positivity with a very low CD4 T-cell count (20/μL) was found, and the viral load was 100 400 HIV-RNA copies/ml. The serum was positive for anti-Toxoplasma IgG antibodies (> 200 IU/mL), IgM negative, and IgA borderline. As toxoplasmic encephalitis and retinitis were suspected, antitoxoplasmic therapy with pyrimethamine, spiramycin, and folinic acid was started. The ophthalmologist considered cytomegalovirus retinitis, which was not confirmed by serology or PCR. In contrast, the presence of IgG antibodies in ocular fluid and serum with the calculation of the Goldmann-Witmer coefficient (GW = 32) as well as PCR DNA positivity pointed to Toxoplasma gondii as the etiological agent. Follow-up MRI scan confirmed regression of the pathological lesions, neurological deficit also improved, CD4 T-lymphocytes increased above 200/μL, but blindness of the left eye persisted.

Conclusion: CT and MRI scans offered no clue as to Toxoplasma etiology of the brain and eye involvement in an HIV-positive patient, which was only confirmed by laboratory tests. Due to the delay in the diagnosis of toxoplasmosis, time from the epileptic seizure to treatment initiation was 16 days, which assumedly caused irreversible blindness in the patient.

Keywords:

Toxoplasma gondii – cerebral toxoplasmosis – ocular toxoplasmosis – HIV/AIDS patient

Zdroje

1. Reiter-Owona I, Seitz H, Gross U, et al. Is stage conversion the inigtiating event for reactivation of Toxoplasma gondii in tissue of AIDS patients? J Parasitol, 2000; 86(3):531–536.

2. Strabelli TMV, Siciliano RF, Campos SV, et al. Toxoplasma gondii myokarditis after adult heart transplantation: Successful prophylaxis with pyrymethamine. J Trop Med, 2012; 2012: 853562.

3. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Inf Dis, 1992; 15(2):211–222.

4. Conrath J, Mouly-Bandini A, Collart F, Ridings B. Toxoplasma gondii retinochoroiditis after cardiac transplantation. Graefes Arch Clin Exp Ophthalmol, 2003; 241(4):334–338.

5. Strhársky J, Maďarová L., Klement C. Laboratórna diagnostika toxoplazmózy. Epidemiol Mikrobiol Imunol, 2009; 58(2):51–52.

6. Boldiš, V., Ondriska, F., Kováč, Ľ., Ondriska, M. et al. Kazuistika toxoplazmovej meningoencefalitídy s fatálnym koncom u HIV pacienta. Newslab, 2020; 11(1):47–50.

7. Staňková M, Špála J, Neuwirth J. Toxoplasma encephalitis in HIV positive patients. Slov. Lek, 1992; 2:8–11.

8. Kaplan JE, Benson C, Holmes KH. et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009; 58: 1–207.

9. Testi I, Mahajan S, Agrawal R, et al. Management of Intraocular Infections in HIV. Ocul Immunol Inflamm, 2020 [cit. 20.12.2021] Dostupné na: <https://doi.org/10.1080/09273948.2020.1727533>.

10. Crosson JN, Laird PV, Grossniklaus HE, Hendrick AM. Toxoplasma chorioretinitis diagnosed by histopathology in a patient with AIDS. Retin Cases Brief Rep, 2015; 9(2):162–163.

11. Pierce M, Johnson M, Maciunas R. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med, 1995;123(8):594–599.

12. Xavier GA, Cademartori BG, da Cunha Filho NA, et al. Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil. Rev Inst Med Trop de São Paulo, 2013; 55(1):25–30.

13. Reiber H. Die diagnostische Bedeutung neuroimmunologischer reaktionsmuster im Liquor cerebrospinalis. J LabMed, 1995; 19:444–462.

14. Couvreur J, Thuliez P. Acquired toxoplasmosis of ocular or neurologic site: 49 cases. Presse Med, 1996; 25(9):438–442.

15. Ronday MJ, Ongkosuwito JV, Rothova A, Kijlstra A. Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol, 1999; 127(3):294–300.

16. Garweg JG. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol, 2005;27(3):61–68.

17. Rabaud C, May T, Amiel C, et al. Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey. Medicine (Baltimore,) 1994; 73(6):306–14.

18. Oksenhendler E, Duarte M, Soulier J, Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 p et al.atients. AIDS, 1996; 10(1):61–67.

19. Katusiime Ch. Cerebral toxoplasmosis in an HIV negative patient: the first documented case report in Africa and literature review. Clin Pract, 2018; 15(SI):619–623.

20. Del Valle L, Pina-Oviedo S. HIV disorders of the brain; pathology et pathogenesis. Front Biosci, 2006; 11(1):718–732.

21. Fard SA, Khajeh A, Khosravi A, et al. Fulminant and Diffuse Cerebral Toxoplasmosis as the First Manifestation of HIV Infection: A Case Presentation and Review of the Literature. Am J Case Rep, 2020; 21: e919624-1–e919624-6.

22. Basavaraju A. Toxoplasmosis in HIV infection: An overview. Trop Parasitol, 2016; 6(2):129–135.

23. Abdollahi A, Mohraz M, Rasoulinejad M et al., Retinitis due to Opportunistic Infections in Iranian HIV Infected Patients. Acta Medica Iranica, 2013; 51(10):710–714.

24. Park YH, Nam JW. Clinical properties and treatment of ocular toxoplasmosis. Korean J Parasitol, 2013; 51(4):393–399.

25. Ded-la-Torre A, Gómez-Marín J. Disease of the Year 2019: Ocular Toxoplasmosis in HIV-infected Patients. Ocul Immunol Inflamm, 2020; 28 (7):1031–1039.

26. Zajdenweber M, Muccioli C, Belfort JR. Ocular involvement in AIDS patients with central nervous system toxoplasmosis: before and after HAART. Arq Bras Oftalmol, 2005; 68(6):773–775.

27. Alves JM, Magalhães V, Gomes de Matos MA. Toxoplasmic retinochoroiditis in patients with AIDS and neurotoxoplasmosis. Arq Bra Oftalmol, 2010; 73(2):150–154.

28. Pour EK, Esfahani FR, Ebrahimiadib N. et al. Acquired Immunodeficiency Syndrome presented as atypical ocular toxoplasmosis. Case Rep Ophthalmol Med, 2021; Article ID 5512408, 6 pages. Dostupný na <https://doi.org/10.1155/2021/5512408>.

29. Gagliuso DJ, Teich SA, Friedman AH, Orellana J. Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc. 1990; 88:63–88.

30. Machala L, Kodym P, Malý M, et al. Toxoplasmóza u imnokompromitovaných pacientů. Epidemiol Microbiol Imunol, 2015; 64(2):59–65.

31. Geleneky M, Prášil P, Kodym P. Doporučený postup pro diagnostiku a léčbu toxoplasmózy. Doporučený postup Společnosti infekčního lékařství České lékařské společnosti J.E.Purkyňe. 2017. Dostupný na: <http://www.infekce.cz/DoporToxo17.htm.2017>, 16 s.

32. Kodym P, Malý M, Beran O, et al. Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients. Epidemiol Infect 2015; 143(3):600–607.

33. Solomou A, Lekkou A, Patsoura M, Karavoulias C. Case 13761 Ocular toxoplasmosis in HIV patients-MRI findings 2016. [cit. 2022-03-17]; Dostupný na: <http://www.eurorad.org/case.php?id=13761>.

34. Stanford MR, Gras L, Wade A, Gilbert RE. Reliability of expert interpretation of retinal photographs for the diagnosis of Toxoplasma retinochoroiditis. Br J Ophthalmol, 2002; 86:636–639.

35. Ozgonul C, Besirli CG. Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis. Ophthalmic Res 2017; 57(1):1–12.

36. Greigert V, Pfaff AW, Sauer A, et al. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study. mSphere, 2019; 4(5): e00636-194:e00636-19.

37. Bourdin C, Busse A, Kouamou E, et al. PCR-Based Detection of Toxoplasma gondii DNA in Blood and Ocular Samples for Diagnosis of Ocular Toxoplasmosis. J Clin Microbiol, 2014; 52(11):3987–3991.

38. Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 2008; 46:1965–1967.

39. Pereira NMD, Shah I, Lala M. Toxoplasmosis with chorioretinitis in an HIV-infected child with no visual complaints—importance of fundus examination. Oxford Medical Case Reports, 2017; 01:1–3.